Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
60.621,27
-0,29%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Gracell Biotechnologies Inc (GRCL) Gracell Biotechnologies Inc (GRCL) Notizie

Gracell Biotechnologies Inc

GRCL
10,25
0,00 (0,00%)
10 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
04/3/202418:22EDGAR2Form 15-12G - Securities registration termination [Section..
28/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
26/2/202423:28EDGAR2Form S-8 POS - Securities to be offered to employees in..
26/2/202423:28EDGAR2Form POS AM - Post-Effective amendments for registration..
26/2/202423:26EDGAR2Form POS AM - Post-Effective amendments for registration..
26/2/202423:26EDGAR2Form S-8 POS - Securities to be offered to employees in..
22/2/202414:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/2/202414:45GLOBEGracell Biotechnologies Acquisition Completed
20/2/202414:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/2/202413:45GLOBEGracell Biotechnologies Announces Shareholders’ Approval of..
14/2/202414:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/1/202412:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/1/202413:00GLOBEGracell Biotechnologies Announces FDA Clearance of IND..
17/1/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202416:06PRNUSKuehn Law Encourages KRTX, DSKE, RYZB, and GRCL Investors to..
26/12/202314:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/12/202312:44DJNGracell ADSs Take Flight Premarket on $1.2 Billion Takeover..
26/12/202309:05DJNAstraZeneca to Buy Gracell Biotechnologies for $1.2 Billion
26/12/202308:01BWAstraZeneca to acquire Gracell, furthering cell therapy..
26/12/202308:00GLOBEGracell Biotechnologies to be acquired by AstraZeneca,..
22/12/202312:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202313:00GLOBEGracell Biotechnologies Announces China NMPA Clearance for..
18/12/202322:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/12/202301:30GLOBEGracell Biotechnologies Presents Updated Clinical Data from..
29/11/202312:18IHMARKETNEWSAmazon Unveils Innovative Services, Okta Discloses Data..
28/11/202320:59DJNCabaletta Bio Down as FDA Looks Into Issues With Several..
27/11/202314:00GLOBEGracell Biotechnologies Announces FDA Clearance of IND..
21/11/202312:25EDGAR2Form 144 - Report of proposed sale of securities
16/11/202314:00GLOBEGracell Biotechnologies to Participate in Inaugural Cell..
14/11/202312:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/11/202313:30GLOBEGracell Biotechnologies Reports Third Quarter 2023 Unaudited..
08/11/202314:30GLOBEGracell Biotechnologies Wins Overall Immunology Solution of..
02/11/202314:00GLOBEGracell Biotechnologies to Present Updated Results from..
01/11/202321:00GLOBEGracell Biotechnologies to Participate in Four Upcoming..
31/10/202314:00GLOBEGracell Biotechnologies to Present Data Highlighting..
30/10/202313:30GLOBEGracell Biotechnologies to Report Third Quarter 2023..
29/9/202312:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/9/202314:30GLOBEGracell Biotechnologies Reports Updated Clinical Data for..
27/9/202312:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/9/202322:00GLOBEGracell Biotechnologies Doses First Patient in Phase 1b/2..
19/9/202315:21GLOBEGracell Biotechnologies’ CEO Dr. William Cao Named to..
14/9/202315:15GLOBEGracell Biotechnologies to Participate in Three Upcoming..
12/9/202322:12EDGAR2Form F-3/A - Registration statement by foreign private..
06/9/202314:00PRNUSGracell Biotechnologies to Present Updated Clinical Data on..
24/8/202322:10GLOBEGracell Biotechnologies to Participate in Two Upcoming..
24/8/202322:03EDGAR2Form F-3 - Registration statement by foreign private issuers
23/8/202312:47EDGAR2Form 144 - Report of proposed sale of securities
18/8/202322:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/8/202322:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
Apertura: Min: Max:
Chiusura: 10,25

La tua Cronologia

NASDAQ
GRCL
Gracell Biotechnologies
NYSE
ICNC
Iconic Sports Acquisition
COIN
MONNBTC
MonfterToken
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network